Active, Not Recruiting
Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
NCT04268706
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Disease Recurrent, +10 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States